Literature DB >> 12048287

The central nervous system in systemic lupus erythematosus. Part 2. Pathogenetic mechanisms of clinical syndromes: a literature investigation.

F G I Jennekens1, L Kater.   

Abstract

OBJECTIVES: To identify the pathogenetic mechanisms of central nervous system (CNS) syndromes of systemic lupus erythematosus (SLE) as described in the literature.
METHODS: Using PUBMED, we performed a systematic search of publications from 1980 onwards. Studies were eligible if they had been performed on patients or material from patients with CNS manifestations and definite SLE and when the CNS manifestations were not secondary. Criteria were formulated for the identification of pathogenetic mechanisms.
RESULTS: The single most important cause of the CNS syndromes of SLE is ischaemia due to narrowing or occlusion of small vessels, arteries and veins. Antiphospholipid antibodies and premature atherosclerosis play roles in these processes, but they have not been delineated definitely. Intracranial and intraspinal haemorrhages are much less frequent than ischaemia and are presumably in part due directly to SLE. Vasculitis may cause ischaemia or haemorrhage in the CNS and is involved occasionally, as shown by imaging and histological findings. White matter damage is heterogeneous and ill-understood. It includes white matter degeneration and myelin vacuolation of the spinal cord, and reversible leucoencephalopathy due to oedema. Antibody-induced neuronal dysfunction in the CNS is a realistic hypothesis and may involve anti-ribosomal P antibodies and several other antibodies. Deficiency of psychological reactions forms a separate and entirely different category of mechanisms.
CONCLUSIONS: Causes have been identified or possible causes have been suggested for most of the CNS syndromes of SLE, thus offering rationales for different forms of prevention and therapy.

Entities:  

Mesh:

Year:  2002        PMID: 12048287     DOI: 10.1093/rheumatology/41.6.619

Source DB:  PubMed          Journal:  Rheumatology (Oxford)        ISSN: 1462-0324            Impact factor:   7.580


  28 in total

1.  Varicella-zoster vasculitis presenting with intracranial hemorrhage.

Authors:  Rajan Jain; John Deveikis; Susan Hickenbottom; Suresh K Mukherji
Journal:  AJNR Am J Neuroradiol       Date:  2003-05       Impact factor: 3.825

Review 2.  Neuroimmunopathology in a murine model of neuropsychiatric lupus.

Authors:  David A Ballok
Journal:  Brain Res Rev       Date:  2006-12-20

Review 3.  Hashimoto's encephalopathy : epidemiology, pathogenesis and management.

Authors:  Ramon Mocellin; Mark Walterfang; Dennis Velakoulis
Journal:  CNS Drugs       Date:  2007       Impact factor: 5.749

4.  Human lupus autoantibodies against NMDA receptors mediate cognitive impairment.

Authors:  Czeslawa Kowal; Lorraine A Degiorgio; Ji Y Lee; Mark A Edgar; Patricio T Huerta; Bruce T Volpe; Betty Diamond
Journal:  Proc Natl Acad Sci U S A       Date:  2006-12-14       Impact factor: 11.205

Review 5.  Immunologically mediated dementias.

Authors:  Michael H Rosenbloom; Sallie Smith; Gulden Akdal; Michael D Geschwind
Journal:  Curr Neurol Neurosci Rep       Date:  2009-09       Impact factor: 5.081

6.  Acute parkinsonism as first manifestation of systemic lupus erythematosus unmasked by CMV infection.

Authors:  Marco Marino; Francesca Morgante; Federica Montagnese; Antonio Toscano; Olimpia Musumeci
Journal:  Neurol Sci       Date:  2014-06-01       Impact factor: 3.307

7.  Deep brain reversible encephalopathy: association with secondary antiphospholipid antibody syndrome.

Authors:  T Parikh; K Shifteh; M L Lipton; J A Bello; A L Brook
Journal:  AJNR Am J Neuroradiol       Date:  2007-01       Impact factor: 3.825

8.  Relationship between clinical factors and neuropsychiatric manifestations in systemic lupus erythematosus.

Authors:  Yasuhiro Shimojima; Masayuki Matsuda; Takahisa Gono; Wataru Ishii; Shu-ichi Ikeda
Journal:  Clin Rheumatol       Date:  2005-03-02       Impact factor: 2.980

9.  Transient life-threatening cerebral edema in a patient with systemic lupus erythematosus.

Authors:  Matt T Bianchi; Catherine Lavigne; Farzaneh Sorond; Bonnie Bermas
Journal:  J Clin Rheumatol       Date:  2009-06       Impact factor: 3.517

10.  Comparison of the clinical manifestations, brain MRI and prognosis between neuroBeçhet's disease and neuropsychiatric lupus.

Authors:  Byung-Sik Cho; Hyun-Sook Kim; Su-Jin Oh; Hyeok-Jae Koh; Chong-Hyun Yoon; So-Lyung Jung; Do-June Min; Wan-Uk Kim
Journal:  Korean J Intern Med       Date:  2007-06       Impact factor: 3.165

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.